Open versus laparoscopic adrenalectomy for adrenocortical carcinoma: a meta-analysis of surgical and oncological outcomes

R Autorino, P Bove, M De Sio, R Miano, S Micali… - Annals of surgical …, 2016 - Springer
Purpose This study was designed to determine the role of laparoscopic adrenalectomy (LA)
in the surgical management of adrenocortical carcinoma (ACC). Methods A systematic …

[PDF][PDF] Comprehensive pan-genomic characterization of adrenocortical carcinoma

S Zheng, AD Cherniack, N Dewal, RA Moffitt… - Cancer cell, 2016 - cell.com
We describe a comprehensive genomic characterization of adrenocortical carcinoma (ACC).
Using this dataset, we expand the catalogue of known ACC driver genes to include …

Surgical management of adrenocortical carcinoma: an evidence-based approach

J Datta, RE Roses - Surgical Oncology Clinics, 2016 - surgonc.theclinics.com
Adrenocortical carcinoma (ACC) is a rare malignancy with an annual incidence of 1 to 2
cases per million individuals. 1 Notwithstanding, frequent presentation with sequelae of …

Nomograms to predict recurrence-free and overall survival after curative resection of adrenocortical carcinoma

Y Kim, GA Margonis, JD Prescott, TB Tran… - JAMA …, 2016 - jamanetwork.com
Importance Adrenocortical carcinoma (ACC) is a rare but aggressive endocrine tumor, and
the prognostic factors associated with long-term outcomes after surgical resection remain …

Adrenocortical carcinoma: impact of surgical margin status on long-term outcomes

GA Margonis, Y Kim, JD Prescott, TB Tran… - Annals of surgical …, 2016 - Springer
Background The influence of surgical margin status on long-term outcomes of patients
undergoing adrenal resection for ACC remains not well defined. We studied the impact of …

Outcomes of adjuvant mitotane after resection of adrenocortical carcinoma: a 13-institution study by the US Adrenocortical Carcinoma Group

LM Postlewait, CG Ethun, TB Tran, JD Prescott… - Journal of the American …, 2016 - Elsevier
Background Current treatment guidelines recommend adjuvant mitotane after resection of
adrenocortical carcinoma with high-risk features (eg, tumor rupture, positive margins …

Management of adrenocortical carcinoma: a consensus statement of the Italian Society of Endocrinology (SIE)

A Stigliano, I Chiodini, R Giordano, A Faggiano… - Journal of …, 2016 - Springer
Accepted: 23 June 2015/Published online: 14 July 2015© Italian Society of Endocrinology
(SIE) 2015 advanced ACC remains disappointing for limited efficacy and significant toxicity …

Lymphadenectomy for adrenocortical carcinoma: is there a therapeutic benefit?

JM Gerry, TB Tran, LM Postlewait, SK Maithel… - Annals of surgical …, 2016 - Springer
Background Lymph node metastasis is an established predictor of poor outcome for
adrenocortical carcinoma (ACC); however, routine lymphadenectomy during surgical …

Curative resection of adrenocortical carcinoma: rates and patterns of postoperative recurrence

N Amini, GA Margonis, Y Kim, TB Tran… - Annals of surgical …, 2016 - Springer
Background Adrenocortical carcinoma (ACC) is a rare malignancy. The aim of this study was
to determine the incidence and patterns of recurrence after curative-intent surgery for ACC …

Actual 10‐year survivors following resection of adrenocortical carcinoma

TB Tran, LM Postlewait, SK Maithel… - Journal of surgical …, 2016 - Wiley Online Library
Background Adrenocortical carcinoma (ACC) is a rare and aggressive malignancy with
limited therapeutic options beyond surgical resection. The characteristics of actual long‐term …